Pharmaceutical company
Roche Pakistan Ltd
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
11products
5generics
0therapeutic areas
11current prices
Portfolio intelligence
Therapeutic mix
Unclassified 11
Company portfolio
11 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Avastin | Bevacizumab | 400 mg/16 mL | Concentrate for solution for infusion | 1's | 043005 | PKR 236,486.52 |
| Avastin | Bevacizumab | 100 mg/4 mL | Injection | 1's | 043004 | PKR 59,483.08 |
| Herceptin SC | Trastuzumab | 600 mg/5 mL (120 mg/mL) | Subcutaneous injection | 1's | 088527 | PKR 252,394.98 |
| Mabthera | Rituximab | 1400 mg/11.7 mL (120 mg/mL) | Solution for subcutaneous injection | 1's | 094764 | PKR 185,708.68 |
| Mabthera | Rituximab | 1600 mg/13.4 mL (120 mg/mL) | Solution for subcutaneous injection | 1's | 094765 | PKR 211,032.59 |
| Mircera | Methoxy polyethylene glycol-epoetin beta | 75 mcg/0.3 mL | Prefilled syringe injection | 1's | 059051 | PKR 23,816.36 |
| Mircera | Methoxy polyethylene glycol-epoetin beta | 50 mcg | Prefilled syringe injection | 1's | 059052 | PKR 15,862.15 |
| Mircera PFS | Methoxy polyethylene glycol-epoetin beta | 100 mcg/0.3 mL | Prefilled syringe injection | 1's | 059050 | PKR 26,436.92 |
| Ristova | Rituximab | 100 mg/10 mL | Injection | 2's | 031394 | PKR 71,255.76 |
| Ristova | Rituximab | 500 mg/50 mL | Injection | 1's | 031395 | PKR 176,590.37 |
| Tamiflu , containing | Oseltamivir | 75 mg | Capsule | 10's | 039619 | PKR 2,650.16 |